title: Interleukin-2-based immunotherapy in the management of minimal residual disease in acute leukemia patients.
authors.affiliation: Dipartimento di Scienze Biomediche e Oncologia Umana, University of Turin, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Foa
authors.forename: G
authors.initials: G
authors.lastname: Meloni
authors.forename: A
authors.initials: A
authors.lastname: Guarini
authors.forename: M
authors.initials: M
authors.lastname: Vignetti
authors.forename: D
authors.initials: D
authors.lastname: Marchis
authors.forename: S
authors.initials: S
authors.lastname: Tosti
authors.forename: A
authors.initials: A
authors.lastname: Gillio Tos
authors.forename: F
authors.initials: F
authors.lastname: Mandelli
authors.forename: F
authors.initials: F
authors.lastname: Gavosto
mesh_terms: D000208:Acute Disease; D000818:Animals; D006801:Humans; D007167:Immunotherapy; D007376:Interleukin-2 / Q000627:therapeutic use*; D015979:Killer Cells, Lymphokine-Activated / Q000276:immunology; D007938:Leukemia / Q000628:therapy*; D051379:Mice; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D007376:Interleukin-2; D011994:Recombinant Proteins